Gnosis Fuels Mood & Brain Health Innovation with Adonat® Premium SAMe Relaunch

Share this article:

press-release_adonat_gnosis

A key global player in ingredients developed from fermentation, Gnosis by Lesaffre expands its reach for Mood & Cognitive Health solutions in 2023 with a new production line expansion dedicated to its star ingredient: Adonat® Premium SAMe (S-Adenosyl-L-Methionine). 

SAMe is a natural molecule supporting healthy mood and emotional well-being since it is directly involved in the neurotransmitter’s synthesis.  It also sustains cognitive functions, being one of the most important factors studied counteracting alterations in brain structures and functions, intimately tied to the aging process. Further, SAMe applies to supporting liver and joint health.

An aging global population, the rise in neurodegenerative diseases, the COVID-19 pandemic, and the most recent phenomenon of digital dementia have amplified consumer demand for SAMe, increasing the traction for brain & mood health solutions. To that end, Gnosis, the key SAMe manufacturer, was motivated to pursue new opportunities for growth and best serve our partners. 

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.